What To Know
- According to a statement by China’s Chamber of Commerce for Import and Export of Medicines and Health Products, the country is tightening rules around the procurement of foreign-made medical equipment in its public hospitals.
- With China being the second-largest healthcare market in the world after the United States, this development could deliver a significant blow to EU manufacturers, many of whom are already dealing with inflation, regulatory changes, and supply chain instability in other global regions.
International Business News: Tensions Escalate Over Medical Tech Trade
A new front has opened in the escalating trade dispute between China and the European Union. Just days after the EU imposed fresh tariffs on Chinese-made electric vehicles, Beijing has responded with its own countermeasure—this time, taking aim at the medical device sector. According to a statement by China’s Chamber of Commerce for Import and Export of Medicines and Health Products, the country is tightening rules around the procurement of foreign-made medical equipment in its public hospitals. While no official ban has been announced, the new regulations appear to significantly favor domestic manufacturers.
China is now focused on generating its own generic drugs so as to not rely on EU imports.
Image Credit: Freepik
China’s retaliatory move, which took effect last Friday, applies to essential medical devices such as ultrasound scanners, ECG machines, and MRI systems. This International Business News report notes that under the updated criteria, public hospitals must prioritize Chinese-made equipment unless a compelling reason is given to source from abroad. The policy is seen as a direct response to what Beijing views as “unjustified” and “discriminatory” measures from the EU targeting Chinese industrial exports.
EU Firms at Risk of Losing Market Share
European medical device giants such as Siemens Healthineers, Philips, and other niche technology suppliers now face the real possibility of losing access to lucrative Chinese government contracts. These state-run hospitals represent one of the largest buyers of medical technologies in the country. With China being the second-largest healthcare market in the world after the United States, this development could deliver a significant blow to EU manufacturers, many of whom are already dealing with inflation, regulatory changes, and supply chain instability in other global regions.
The policy shift could also have ripple effects across the broader med-tech industry. Analysts predict that smaller European firms, particularly those with limited presence in China, might pull out entirely, unable to compete with Beijing-backed rivals enjoying regulatory and financial advantages at home.
China Signals Long-Term Strategy
Industry insiders believe China’s move is not just a tit-for-tat response but part of a deeper strategy to boost self-sufficiency in high-value sectors. The Chinese government has been vocal about reducing dependence on foreign technology, especially in sensitive areas like healthcare, semiconductors, and AI. While the EU contends that its EV tariffs were based on findings of unfair state subsidies, China’s new measures further deepen concerns about an ongoing economic decoupling between two of the world’s largest trade blocs.
As geopolitical and commercial tensions grow, the path to resolution appears increasingly complex. Experts warn that mutual retaliation in strategic sectors like healthcare could result in higher costs, slower innovation, and reduced patient access to cutting-edge medical technology.
For the latest International Business News, keep on logging to Bangkok Business News.
